CTRI/2020/10/028675尚未招募未知
Clinical and immunological factors predicting relapse in patients with pemphigustreated with rituximab: A prospective cohort study
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with confirmed pemphigus vulgaris or foliaceus treated with RTX- RA protocol.
排除标准
- •1. Patients who have received RTX cycles in the preceding one year.
- •2. Patients with other concomitant autoimmune diseases.
- •3. Pregnant and lactating patients.
- •4. Patients who cannot come for follow up visits for at least 18 months.
研究者
相似试验
尚未招募
不适用
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000047162Kobe University114
已完成
不适用
Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis with Endoscopically Normal Mucosalcerative colitisJPRN-UMIN000029800Kitasato University Kitasato Institute Hospital150
进行中（未招募）
1 期
A study searching for the factors predicting ketamine´s antidepressant effectEUCTR2018-001539-39-CZárodní ústav duševního zdraví40
已完成
不适用
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell LymphomaDiffuse Large B-cell LymphomaNCT01369784Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea158
Unknown
不适用
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung CancerLung CancerNCT04918836University Hospital, Brest150